Nano Drug Delivery Systems for Colon Cancer

Dr. Arun Kumar Singh is an assistant professor in the Department of Pharmacy at Vivekanand Global University, Jaipur. He completed both his MPharm in Pharmaceutics and his PhD at Galgotias University, Greater Noida. His research strengths lie in AI-driven cancer research, nano-formulation, and the intersection of blockchain, IoT, machine learning, big data, and neuroscience with pharmaceutical science. He has authored books and contributed chapters on big data and cancer, and his work includes reviews published in reputable journals. His research appears across publishers such as IOP, Elsevier, CRC Press, and Wiley, reflecting a broad publication record and ongoing contributions to AI-enabled oncology and advanced drug delivery. Vipan Kumar is working as a Professor (Associate) at Department of Pharmaceutical Chemistry, JCDM College of Pharmacy, Sirsa. Dr. Kumar has more than 10 years of teaching and research experience. He has published dozens of publications in peer-reviewed international and national journal. He has authored 2 books. Dr. Kumar is an editorial and reviewer board member of several scientific journals of intentional repute. He is also serving as a CPCSEA Nominee in various institutes’ IAEC committees and served in University PGBOS committees. Dr. Prabhakar is a Professor in the Department of Biotechnology at Nagaland University, Kohima, India. He has been recognized among leading global scientists by Stanford’s annual Top Scientists list. He earned his PhD in Biotechnology from IIT Madras. His research centers on molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders using natural products. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society, and contributes as an editorial board member and reviewer for multiple journals. Dr. Prabhakar has received honors including a travel grant to a European conference supported by IIT Madras and CSIR, and funding approved by the Department of Science and Technology. He has published a substantial body of work, authored or edited several books, contributed many chapters, and given numerous talks and poster presentations at conferences. Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with over 18 years of experience in pharmaceutical sciences. She holds a Master’s degree from NIPER Mohali and a Ph.D. from IIT-BHU Varanasi, specializing in medicinal chemistry and CNS drug delivery targeting 5HT1A/2A receptors. Dr. Dhanawat’s research spans synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, and herbal drug extraction. She has published 75 research articles and reviews, holds 5 patents, authored 6 books, contributed 13 book chapters, and edited 5 books. An active participant in national and international conferences, she has received prestigious grants from AAPS, DBT, and DST, along with the Rajiv Gandhi National Fellowship. Dr. Dhanawat’s work significantly advances pharmaceutical innovation and education, reflecting her commitment to scientific excellence and mentorship Dr. Neeraj Mishra is a Professor at the Amity Institute of Pharmacy, Gwalior, where he has served since July 2019. He has over 20 years of teaching and research experience and more than 150 international and national publications in novel, localized, targeted, and controlled drug delivery systems, including nano- and microparticles for the treatment of breast and colon cancer and neurodegenerative disorders. Dr. Mishra has authored 25 books and 45 book chapters with leading publishers such as Elsevier, Bentham, Springer, and Wiley, and holds five patents (three international and two Indian). His honors include the Distinguished Professor Awards (2019, 2021), Outstanding Scientist Award (2020), and Best Academician Award (2023). In 2025, he was recognized as one of the World’s Top 2% Scientists by Stanford University and Elsevier.

• 1. Etiology and pathophysiology of colon cancer2. Current trends of targeted nanoparticulate carriers for the treatment of colon cancer3. Lipid nanocarrier-based drug delivery for the treatment of colon cancer4. Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy5. siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Colon Cancer6. Carbon-Based Quantum Dots and Nanotubes for Colon Cancer Targeting and Drug Delivery7. Recent trends of extracellular vesicles for therapeutic intervention of Colon Cancer8. Mitochondria-targeted drug delivery systems for the effective treatment of colon cancer9. Revolutionizing Colon Cancer Care: Advances in Carbon-Based Materials as theranostic agents10. Surface modified Metal Nanoparticles in Colon Cancer Therapy11. Nano-based Phyto drug delivery systems for the management of colon cancer12. Role of polymeric nanoparticles for the treatment of Colon cancer13. Nanomicelles based drug delivery systems as for targeted therapy of colon cancer14. Regulatory framework in the Nanomedicine targeting Colon Cancer15. Current and future perspectives of nanomedicine in colon cancer treatment